PolyPid (NASDAQ: PYPD) has announced the appointment of medtech leader Brooke Story as chair of the board of directors (BOD), effective December 11, 2025.
Ms. Story brings more than 25 years of leadership experience in the medtech industry, having held senior roles at Becton, Dickinson and Company, and Medtronic PLC.
In a statement, Dikla Czaczkes Akselbrad, CEO of PolyPid, commented, “Brooke’s appointment marks an exciting and pivotal moment for PolyPid. Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transforming our clinical success into a commercial reality.”
Ms. Story added, “I am honored to join PolyPid at this pivotal stage in the company’s development. I look forward to supporting the team as it leverages its delivery platform to address critical, high-cost needs in surgical infection prevention, creating a clear opportunity to build significant enterprise value and bring potentially transformative solutions to the healthcare market.”
